Inozyme Pharma Inc (INZY)
3.42
-0.13
(-3.66%)
USD |
NASDAQ |
Nov 14, 16:00
3.50
+0.08
(+2.34%)
After-Hours: 20:00
Inozyme Pharma Shareholders Equity (Quarterly): 82.79M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 82.79M |
| June 30, 2024 | 94.42M |
| March 31, 2024 | 118.84M |
| December 31, 2023 | 140.48M |
| September 30, 2023 | 160.21M |
| June 30, 2023 | 105.59M |
| March 31, 2023 | 103.35M |
| December 31, 2022 | 118.39M |
| September 30, 2022 | 134.78M |
| June 30, 2022 | 149.18M |
| Date | Value |
|---|---|
| March 31, 2022 | 94.23M |
| December 31, 2021 | 109.27M |
| September 30, 2021 | 125.97M |
| June 30, 2021 | 138.27M |
| March 31, 2021 | 148.89M |
| December 31, 2020 | 158.10M |
| September 30, 2020 | 167.92M |
| June 30, 2020 | -50.02M |
| March 31, 2020 | 70.83M |
| December 31, 2019 | -33.22M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-50.02M
Minimum
Jun 2020
167.92M
Maximum
Sep 2020
106.91M
Average
118.62M
Median
Shareholders Equity (Quarterly) Benchmarks
| Tango Therapeutics Inc | 229.17M |
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
| NovaBay Pharmaceuticals Inc | -0.617M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 143.36M |
| Total Liabilities (Quarterly) | 60.57M |